Word: botox
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...labeled with the unsexy pitch INTENSIVE CONCENTRATE FOR EXISTING STRETCH MARKS (STRIAE DISTENSAE)--that just happens to be one of the chain's Top 10--selling items. No, stretch marks haven't suddenly become big business. But thanks in part to aggressive ads that proclaim it "Better than Botox?," the scientific-sounding StriVectin-SD has become the hottest thing in the war on wrinkles--a booming industry that's generating billions of dollars for dermatologists, cosmetics firms and, yes, retailers like Sephora. "[StriVectin] is driving traffic in our stores," says Sephora vice president Rod McFadden, "and it's having...
...good business, and it's only getting better. Global retail sales of antiaging skin-care products--up 71% since 2000--are rising faster than any other segment of the skin-care market, according to Euromonitor, a market researcher, hitting $9.9 billion last year. More than 2 million Americans got Botox injections and about 1.6 million got chemical peels or microdermabrasions in 2003 (the most recent year for which stats exist). Says Carol Hamilton, president of L'Oréal Paris: "Now you have a whole generation who basically believes that they never have to see a wrinkle. This is a powerful...
StriVectin is either the latest fad in that movement or an antiaging silver bullet, depending on whom you ask. But in either case, it is clearly one of the most talked about new products in the industry, roiling competitors, realigning expectations and even prompting lawsuits--from Botox maker Allergan, which disputes StriVectin's advertising claims, and from StriVectin itself, against alleged copycat marketers pushing similarly named knock-offs. Priced at a hefty $135 per 6-oz. tube, StriVectin, made by privately held Klein-Becker, a division of Salt Lake City, Utah-- based weight-loss-supplement maker Basic Research, last year...
Perhaps most important, though, is the Botox issue. Even as Allergan's litigation with Klein-Becker about StriVectin's "Better than Botox?" ads is pending, the Food and Drug Administration has warned that StriVectin might be reclassified as a drug (which Klein-Becker is seeking to avoid). At the same time, other cosmetics competitors have jumped on the opportunity to compare themselves to Botox. Estée Lauder's Perfectionist is promoted in its ads as the ideal cream "for every woman who says no to Botox"; Avon's Anew Clinical Deep Crease Concentrate jabs at Botox with the line, "look...
...employing teams of chemists, pharmacologists and microbiologists in labs all over the world. And in clinical tests, each company says its cream decreases the depth of fine facial lines to some degree. None of them claim, however, that their products make wrinkles disappear completely, the way a shot of Botox can. Still, the search for a better fountain-of-youth cream continues. Avon is about to complete a $100 million state-of-the-art research facility in Suffern, N.Y. And Clinique last month announced a $7 million research grant devoted to the study of skin with Weill Cornell Medical College...